Switch to:
AbbVie Inc  (NYSE:ABBV) Cost of Goods Sold: \$6,315 Mil (TTM As of Sep. 2017)

AbbVie Inc's cost of goods sold for the three months ended in Sep. 2017 was \$1,616 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Sep. 2017 was \$6,315 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. AbbVie Inc's Gross Margin % for the three months ended in Sep. 2017 was 76.9%.

Cost of Goods Sold is also directly linked to Inventory Turnover. AbbVie Inc's Inventory Turnover for the three months ended in Sep. 2017 was 0.96.

Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

AbbVie Inc Annual Data

 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Cost of Goods Sold 4,508.00 4,581.00 4,426.00 4,500.00 5,833.00

AbbVie Inc Quarterly Data

 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Cost of Goods Sold 1,504.00 1,555.00 1,616.00 1,528.00 1,616.00

Calculation

Cost of goods sold (COGS) refers to the Total Inventories costs of those goods a business has sold during a particular period.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Sep. 2017 was 1555 (Dec. 2016 ) + 1616 (Mar. 2017 ) + 1528 (Jun. 2017 ) + 1616 (Sep. 2017 ) = \$6,315 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

AbbVie Inc's Gross Margin % for the three months ended in Sep. 2017 is calculated as:

 Gross Margin % = (Revenue - Cost of Goods Sold) / Revenue = (6995 - 1616) / 6995 = 76.9 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

AbbVie Inc's Inventory Turnover for the three months ended in Sep. 2017 is calculated as:

 Inventory Turnover = Cost of Goods Sold / Total Inventories = 1616 / 1683.5 = 0.96

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Related Terms

From the Internet

###### Denali Therapeutics Files Raise 100 Million Ipo

- Seekingalpha 2017-11-17 13:43:35

###### Right Time Buy Johnson And Johnson

- Seekingalpha 2017-11-17 11:49:39

###### Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval

- Zacks 2017-11-17 08:05:00

###### Thursday Wal Mart Cisco Cramers Mad Money 11 16 17

- Seekingalpha 2017-11-17 07:43:52

###### Bellicums Momentum Heading Ash 2017

- Seekingalpha 2017-11-17 06:44:30

###### Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3

- Zacks 2017-11-17 06:09:00

###### 40 Dividend Stocks Battling 2018

- Seekingalpha 2017-11-17 03:46:42

###### Miles White of Abbott Labs: Cramer's Top Takeaways

- theStreet 2017-11-16 19:40:00

###### Daily Pharma Scoop Look Sanofi Ultragenyx Gets Fda Nod Capricor Tumbles

- Seekingalpha 2017-11-16 14:35:08

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to \$400 per referral. ( Learn More)